nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—HTR1A—stomach cancer	0.28	1	CbGaD
Imipramine—SLC22A3—Irinotecan—stomach cancer	0.0802	0.243	CbGbCtD
Imipramine—ABCB1—Mitomycin—stomach cancer	0.0492	0.149	CbGbCtD
Imipramine—CYP3A7—Irinotecan—stomach cancer	0.0259	0.0783	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0259	0.0783	CbGbCtD
Imipramine—CYP2B6—Irinotecan—stomach cancer	0.0246	0.0746	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.019	0.0574	CbGbCtD
Imipramine—CYP3A7—Docetaxel—stomach cancer	0.019	0.0574	CbGbCtD
Imipramine—CYP1A2—Fluorouracil—stomach cancer	0.0139	0.042	CbGbCtD
Imipramine—CYP2B6—Doxorubicin—stomach cancer	0.0135	0.0408	CbGbCtD
Imipramine—ABCB1—Irinotecan—stomach cancer	0.0126	0.0382	CbGbCtD
Imipramine—ABCB1—Docetaxel—stomach cancer	0.00926	0.028	CbGbCtD
Imipramine—CYP3A4—Irinotecan—stomach cancer	0.00757	0.0229	CbGbCtD
Imipramine—ABCB1—Doxorubicin—stomach cancer	0.0069	0.0209	CbGbCtD
Imipramine—ABCB1—Methotrexate—stomach cancer	0.00669	0.0202	CbGbCtD
Imipramine—CYP2D6—Doxorubicin—stomach cancer	0.0065	0.0197	CbGbCtD
Imipramine—HTR7—myenteric nerve plexus—stomach cancer	0.00624	0.0704	CbGeAlD
Imipramine—ORM1—bile—stomach cancer	0.00599	0.0675	CbGeAlD
Imipramine—CYP3A4—Docetaxel—stomach cancer	0.00555	0.0168	CbGbCtD
Imipramine—CHRM3—muscle of abdomen—stomach cancer	0.00548	0.0618	CbGeAlD
Imipramine—HTR7—vagus nerve—stomach cancer	0.00416	0.0469	CbGeAlD
Imipramine—CYP3A4—Doxorubicin—stomach cancer	0.00413	0.0125	CbGbCtD
Imipramine—HTR7—vein—stomach cancer	0.00402	0.0454	CbGeAlD
Imipramine—HTR2A—myenteric nerve plexus—stomach cancer	0.00389	0.0439	CbGeAlD
Imipramine—HTR2A—vagus nerve—stomach cancer	0.0026	0.0293	CbGeAlD
Imipramine—HTR2A—vein—stomach cancer	0.00251	0.0283	CbGeAlD
Imipramine—ORM1—gall bladder—stomach cancer	0.00166	0.0187	CbGeAlD
Imipramine—KCND3—pancreas—stomach cancer	0.0014	0.0157	CbGeAlD
Imipramine—HTR7—blood vessel—stomach cancer	0.00128	0.0144	CbGeAlD
Imipramine—CHRM5—epithelium—stomach cancer	0.00117	0.0132	CbGeAlD
Imipramine—CYP2C18—digestive system—stomach cancer	0.00109	0.0122	CbGeAlD
Imipramine—ADRA1D—epithelium—stomach cancer	0.00104	0.0118	CbGeAlD
Imipramine—ORM1—hematopoietic system—stomach cancer	0.00094	0.0106	CbGeAlD
Imipramine—CYP2C18—endocrine gland—stomach cancer	0.000898	0.0101	CbGeAlD
Imipramine—KCND3—liver—stomach cancer	0.000889	0.01	CbGeAlD
Imipramine—SLC6A3—hematopoietic system—stomach cancer	0.000874	0.00986	CbGeAlD
Imipramine—CYP3A7—endocrine gland—stomach cancer	0.000854	0.00963	CbGeAlD
Imipramine—SLC22A2—digestive system—stomach cancer	0.000848	0.00956	CbGeAlD
Imipramine—SLC22A3—hematopoietic system—stomach cancer	0.000823	0.00928	CbGeAlD
Imipramine—CYP2C18—liver—stomach cancer	0.000809	0.00912	CbGeAlD
Imipramine—SLC6A4—hematopoietic system—stomach cancer	0.000801	0.00903	CbGeAlD
Imipramine—HTR2A—blood vessel—stomach cancer	0.000796	0.00897	CbGeAlD
Imipramine—CYP3A7—liver—stomach cancer	0.00077	0.00868	CbGeAlD
Imipramine—SLC22A3—smooth muscle tissue—stomach cancer	0.000725	0.00817	CbGeAlD
Imipramine—HTR1A—hematopoietic system—stomach cancer	0.000711	0.00802	CbGeAlD
Imipramine—KCND3—lymph node—stomach cancer	0.000682	0.00768	CbGeAlD
Imipramine—HTR7—hematopoietic system—stomach cancer	0.00068	0.00766	CbGeAlD
Imipramine—CYP2C19—hematopoietic system—stomach cancer	0.000664	0.00748	CbGeAlD
Imipramine—ADRA1D—endocrine gland—stomach cancer	0.000656	0.0074	CbGeAlD
Imipramine—ADRA1A—hematopoietic system—stomach cancer	0.000656	0.00739	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—liver—stomach cancer	0.000655	0.00738	CbGeAlD
Imipramine—KCNH2—hematopoietic system—stomach cancer	0.000633	0.00714	CbGeAlD
Imipramine—CHRM3—smooth muscle tissue—stomach cancer	0.000629	0.00709	CbGeAlD
Imipramine—SLC22A4—digestive system—stomach cancer	0.000629	0.00709	CbGeAlD
Imipramine—HTR7—epithelium—stomach cancer	0.000622	0.00701	CbGeAlD
Imipramine—ORM1—bone marrow—stomach cancer	0.000603	0.00679	CbGeAlD
Imipramine—ADRA1A—epithelium—stomach cancer	0.0006	0.00676	CbGeAlD
Imipramine—HTR7—smooth muscle tissue—stomach cancer	0.000599	0.00675	CbGeAlD
Imipramine—SLC22A4—bone marrow—stomach cancer	0.00058	0.00654	CbGeAlD
Imipramine—SLC6A4—digestive system—stomach cancer	0.000557	0.00628	CbGeAlD
Imipramine—CYP1A2—hematopoietic system—stomach cancer	0.000542	0.00611	CbGeAlD
Imipramine—ORM1—endocrine gland—stomach cancer	0.00054	0.00609	CbGeAlD
Imipramine—Mianserin—HRH4—stomach cancer	0.000529	0.0988	CrCbGaD
Imipramine—ABCB1—blood vessel—stomach cancer	0.000522	0.00588	CbGeAlD
Imipramine—CYP2B6—hematopoietic system—stomach cancer	0.00052	0.00586	CbGeAlD
Imipramine—HRH1—hematopoietic system—stomach cancer	0.000508	0.00572	CbGeAlD
Imipramine—CHRM2—endocrine gland—stomach cancer	0.000504	0.00568	CbGeAlD
Imipramine—CHRM3—digestive system—stomach cancer	0.000497	0.0056	CbGeAlD
Imipramine—SLC22A1—endocrine gland—stomach cancer	0.000495	0.00558	CbGeAlD
Imipramine—CYP2E1—hematopoietic system—stomach cancer	0.000488	0.0055	CbGeAlD
Imipramine—ORM1—liver—stomach cancer	0.000487	0.00549	CbGeAlD
Imipramine—SLC22A3—endocrine gland—stomach cancer	0.000473	0.00533	CbGeAlD
Imipramine—HTR7—digestive system—stomach cancer	0.000473	0.00533	CbGeAlD
Imipramine—HRH1—epithelium—stomach cancer	0.000464	0.00523	CbGeAlD
Imipramine—CYP2C19—digestive system—stomach cancer	0.000462	0.0052	CbGeAlD
Imipramine—ADRA1A—lymphoid tissue—stomach cancer	0.000462	0.0052	CbGeAlD
Imipramine—SLC6A4—endocrine gland—stomach cancer	0.00046	0.00519	CbGeAlD
Imipramine—CHRM1—endocrine gland—stomach cancer	0.000459	0.00517	CbGeAlD
Imipramine—HRH1—smooth muscle tissue—stomach cancer	0.000447	0.00504	CbGeAlD
Imipramine—SLC22A1—liver—stomach cancer	0.000446	0.00503	CbGeAlD
Imipramine—Benazepril—MTHFR—stomach cancer	0.00043	0.0804	CrCbGaD
Imipramine—Promethazine—HRH4—stomach cancer	0.000428	0.0801	CrCbGaD
Imipramine—SLC22A3—liver—stomach cancer	0.000427	0.00481	CbGeAlD
Imipramine—Doxepin—HRH4—stomach cancer	0.000424	0.0793	CrCbGaD
Imipramine—HTR2A—hematopoietic system—stomach cancer	0.000424	0.00478	CbGeAlD
Imipramine—CHRM3—endocrine gland—stomach cancer	0.00041	0.00463	CbGeAlD
Imipramine—HTR1A—endocrine gland—stomach cancer	0.000409	0.00461	CbGeAlD
Imipramine—KCNH2—bone marrow—stomach cancer	0.000406	0.00458	CbGeAlD
Imipramine—SLC6A2—endocrine gland—stomach cancer	0.000405	0.00457	CbGeAlD
Imipramine—CYP3A4—hematopoietic system—stomach cancer	0.000393	0.00442	CbGeAlD
Imipramine—HTR7—endocrine gland—stomach cancer	0.000391	0.0044	CbGeAlD
Imipramine—HTR2A—epithelium—stomach cancer	0.000388	0.00437	CbGeAlD
Imipramine—CYP2D6—hematopoietic system—stomach cancer	0.000386	0.00435	CbGeAlD
Imipramine—CYP2C19—endocrine gland—stomach cancer	0.000382	0.0043	CbGeAlD
Imipramine—CYP1A2—digestive system—stomach cancer	0.000377	0.00425	CbGeAlD
Imipramine—ADRA1A—endocrine gland—stomach cancer	0.000377	0.00425	CbGeAlD
Imipramine—ORM1—lymph node—stomach cancer	0.000374	0.00421	CbGeAlD
Imipramine—HTR2A—smooth muscle tissue—stomach cancer	0.000373	0.00421	CbGeAlD
Imipramine—DRD2—endocrine gland—stomach cancer	0.000369	0.00416	CbGeAlD
Imipramine—CYP2B6—lymphoid tissue—stomach cancer	0.000366	0.00413	CbGeAlD
Imipramine—KCNH2—endocrine gland—stomach cancer	0.000364	0.0041	CbGeAlD
Imipramine—CYP2B6—digestive system—stomach cancer	0.000362	0.00407	CbGeAlD
Imipramine—SLC22A4—lymph node—stomach cancer	0.000359	0.00405	CbGeAlD
Imipramine—HRH1—digestive system—stomach cancer	0.000353	0.00398	CbGeAlD
Imipramine—HTR7—liver—stomach cancer	0.000352	0.00397	CbGeAlD
Imipramine—Benazepril—ACE—stomach cancer	0.000351	0.0656	CrCbGaD
Imipramine—CYP2C19—liver—stomach cancer	0.000344	0.00388	CbGeAlD
Imipramine—CYP2E1—lymphoid tissue—stomach cancer	0.000343	0.00387	CbGeAlD
Imipramine—ADRA1A—liver—stomach cancer	0.00034	0.00383	CbGeAlD
Imipramine—CYP2E1—digestive system—stomach cancer	0.000339	0.00382	CbGeAlD
Imipramine—Chlorpromazine—HRH4—stomach cancer	0.000332	0.062	CrCbGaD
Imipramine—Amitriptyline—HRH4—stomach cancer	0.000328	0.0613	CrCbGaD
Imipramine—SLC22A3—lymph node—stomach cancer	0.000327	0.00369	CbGeAlD
Imipramine—CYP1A2—endocrine gland—stomach cancer	0.000312	0.00351	CbGeAlD
Imipramine—CYP2B6—endocrine gland—stomach cancer	0.000299	0.00337	CbGeAlD
Imipramine—HTR2A—digestive system—stomach cancer	0.000295	0.00332	CbGeAlD
Imipramine—HRH1—endocrine gland—stomach cancer	0.000292	0.00329	CbGeAlD
Imipramine—CYP1A2—liver—stomach cancer	0.000281	0.00317	CbGeAlD
Imipramine—CYP2E1—endocrine gland—stomach cancer	0.00028	0.00316	CbGeAlD
Imipramine—SLC6A2—lymph node—stomach cancer	0.00028	0.00316	CbGeAlD
Imipramine—ABCB1—hematopoietic system—stomach cancer	0.000278	0.00313	CbGeAlD
Imipramine—CYP3A4—digestive system—stomach cancer	0.000273	0.00308	CbGeAlD
Imipramine—CYP2B6—liver—stomach cancer	0.000269	0.00304	CbGeAlD
Imipramine—CYP2D6—digestive system—stomach cancer	0.000269	0.00303	CbGeAlD
Imipramine—ABCB1—epithelium—stomach cancer	0.000254	0.00286	CbGeAlD
Imipramine—CYP2E1—liver—stomach cancer	0.000253	0.00285	CbGeAlD
Imipramine—KCNH2—lymph node—stomach cancer	0.000252	0.00284	CbGeAlD
Imipramine—HTR2A—endocrine gland—stomach cancer	0.000244	0.00275	CbGeAlD
Imipramine—ABCB1—pancreas—stomach cancer	0.000226	0.00255	CbGeAlD
Imipramine—CYP3A4—endocrine gland—stomach cancer	0.000226	0.00254	CbGeAlD
Imipramine—Clomipramine—GSTP1—stomach cancer	0.000223	0.0416	CrCbGaD
Imipramine—CYP2D6—endocrine gland—stomach cancer	0.000222	0.0025	CbGeAlD
Imipramine—HTR2A—liver—stomach cancer	0.00022	0.00248	CbGeAlD
Imipramine—CYP3A4—liver—stomach cancer	0.000203	0.00229	CbGeAlD
Imipramine—HRH1—lymph node—stomach cancer	0.000202	0.00227	CbGeAlD
Imipramine—CYP2D6—liver—stomach cancer	0.0002	0.00226	CbGeAlD
Imipramine—ABCB1—lymphoid tissue—stomach cancer	0.000196	0.0022	CbGeAlD
Imipramine—ABCB1—digestive system—stomach cancer	0.000193	0.00218	CbGeAlD
Imipramine—Acepromazine—HTR1A—stomach cancer	0.000184	0.0344	CrCbGaD
Imipramine—Thioproperazine—HTR1A—stomach cancer	0.00018	0.0336	CrCbGaD
Imipramine—ABCB1—bone marrow—stomach cancer	0.000178	0.00201	CbGeAlD
Imipramine—Pipotiazine—HTR1A—stomach cancer	0.000177	0.033	CrCbGaD
Imipramine—Drowsiness—Doxorubicin—stomach cancer	0.00016	0.000977	CcSEcCtD
Imipramine—ABCB1—endocrine gland—stomach cancer	0.00016	0.0018	CbGeAlD
Imipramine—Confusional state—Capecitabine—stomach cancer	0.000159	0.000975	CcSEcCtD
Imipramine—Tachycardia—Docetaxel—stomach cancer	0.000159	0.000975	CcSEcCtD
Imipramine—Skin disorder—Docetaxel—stomach cancer	0.000159	0.00097	CcSEcCtD
Imipramine—Oedema—Capecitabine—stomach cancer	0.000158	0.000967	CcSEcCtD
Imipramine—Infection—Capecitabine—stomach cancer	0.000157	0.000961	CcSEcCtD
Imipramine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000157	0.000958	CcSEcCtD
Imipramine—Dizziness—Irinotecan—stomach cancer	0.000156	0.000955	CcSEcCtD
Imipramine—Jaundice—Doxorubicin—stomach cancer	0.000156	0.000953	CcSEcCtD
Imipramine—Stomatitis—Doxorubicin—stomach cancer	0.000156	0.000953	CcSEcCtD
Imipramine—Anorexia—Docetaxel—stomach cancer	0.000156	0.000952	CcSEcCtD
Imipramine—Shock—Capecitabine—stomach cancer	0.000156	0.000951	CcSEcCtD
Imipramine—Nervous system disorder—Capecitabine—stomach cancer	0.000155	0.000948	CcSEcCtD
Imipramine—Hepatitis—Epirubicin—stomach cancer	0.000155	0.000948	CcSEcCtD
Imipramine—Eye disorder—Methotrexate—stomach cancer	0.000155	0.000947	CcSEcCtD
Imipramine—Diarrhoea—Fluorouracil—stomach cancer	0.000155	0.000947	CcSEcCtD
Imipramine—Thrombocytopenia—Capecitabine—stomach cancer	0.000155	0.000947	CcSEcCtD
Imipramine—Tinnitus—Methotrexate—stomach cancer	0.000154	0.000945	CcSEcCtD
Imipramine—Tachycardia—Capecitabine—stomach cancer	0.000154	0.000944	CcSEcCtD
Imipramine—Hypoaesthesia—Epirubicin—stomach cancer	0.000154	0.000943	CcSEcCtD
Imipramine—Cardiac disorder—Methotrexate—stomach cancer	0.000154	0.00094	CcSEcCtD
Imipramine—Skin disorder—Capecitabine—stomach cancer	0.000154	0.000939	CcSEcCtD
Imipramine—Urinary tract disorder—Epirubicin—stomach cancer	0.000153	0.000936	CcSEcCtD
Imipramine—Hyperhidrosis—Capecitabine—stomach cancer	0.000153	0.000935	CcSEcCtD
Imipramine—Mianserin—HTR1A—stomach cancer	0.000153	0.0286	CrCbGaD
Imipramine—Urethral disorder—Epirubicin—stomach cancer	0.000152	0.000929	CcSEcCtD
Imipramine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000151	0.000924	CcSEcCtD
Imipramine—Anorexia—Capecitabine—stomach cancer	0.000151	0.000922	CcSEcCtD
Imipramine—Angiopathy—Methotrexate—stomach cancer	0.00015	0.000919	CcSEcCtD
Imipramine—Vomiting—Irinotecan—stomach cancer	0.00015	0.000919	CcSEcCtD
Imipramine—Immune system disorder—Methotrexate—stomach cancer	0.00015	0.000915	CcSEcCtD
Imipramine—Dizziness—Fluorouracil—stomach cancer	0.00015	0.000915	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—stomach cancer	0.000149	0.000913	CcSEcCtD
Imipramine—Agranulocytosis—Doxorubicin—stomach cancer	0.000149	0.000912	CcSEcCtD
Imipramine—Rash—Irinotecan—stomach cancer	0.000149	0.000911	CcSEcCtD
Imipramine—Dermatitis—Irinotecan—stomach cancer	0.000149	0.00091	CcSEcCtD
Imipramine—Headache—Irinotecan—stomach cancer	0.000148	0.000905	CcSEcCtD
Imipramine—Insomnia—Docetaxel—stomach cancer	0.000148	0.000903	CcSEcCtD
Imipramine—Paraesthesia—Docetaxel—stomach cancer	0.000147	0.000897	CcSEcCtD
Imipramine—Alopecia—Methotrexate—stomach cancer	0.000146	0.000895	CcSEcCtD
Imipramine—Somnolence—Docetaxel—stomach cancer	0.000145	0.000888	CcSEcCtD
Imipramine—Mental disorder—Methotrexate—stomach cancer	0.000145	0.000888	CcSEcCtD
Imipramine—Eye disorder—Epirubicin—stomach cancer	0.000145	0.000886	CcSEcCtD
Imipramine—Tinnitus—Epirubicin—stomach cancer	0.000145	0.000884	CcSEcCtD
Imipramine—Malnutrition—Methotrexate—stomach cancer	0.000144	0.000882	CcSEcCtD
Imipramine—ABCB1—liver—stomach cancer	0.000144	0.00162	CbGeAlD
Imipramine—Cardiac disorder—Epirubicin—stomach cancer	0.000144	0.00088	CcSEcCtD
Imipramine—Flushing—Epirubicin—stomach cancer	0.000144	0.00088	CcSEcCtD
Imipramine—Vomiting—Fluorouracil—stomach cancer	0.000144	0.00088	CcSEcCtD
Imipramine—Dyspepsia—Docetaxel—stomach cancer	0.000144	0.000879	CcSEcCtD
Imipramine—Hepatitis—Doxorubicin—stomach cancer	0.000143	0.000877	CcSEcCtD
Imipramine—Insomnia—Capecitabine—stomach cancer	0.000143	0.000875	CcSEcCtD
Imipramine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000143	0.000873	CcSEcCtD
Imipramine—Rash—Fluorouracil—stomach cancer	0.000143	0.000872	CcSEcCtD
Imipramine—Dermatitis—Fluorouracil—stomach cancer	0.000143	0.000872	CcSEcCtD
Imipramine—Paraesthesia—Capecitabine—stomach cancer	0.000142	0.000868	CcSEcCtD
Imipramine—Decreased appetite—Docetaxel—stomach cancer	0.000142	0.000868	CcSEcCtD
Imipramine—Headache—Fluorouracil—stomach cancer	0.000142	0.000867	CcSEcCtD
Imipramine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000142	0.000866	CcSEcCtD
Imipramine—Dysgeusia—Methotrexate—stomach cancer	0.000141	0.000864	CcSEcCtD
Imipramine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000141	0.000862	CcSEcCtD
Imipramine—Fatigue—Docetaxel—stomach cancer	0.000141	0.000861	CcSEcCtD
Imipramine—Angiopathy—Epirubicin—stomach cancer	0.000141	0.00086	CcSEcCtD
Imipramine—Urethral disorder—Doxorubicin—stomach cancer	0.000141	0.00086	CcSEcCtD
Imipramine—Nausea—Irinotecan—stomach cancer	0.00014	0.000858	CcSEcCtD
Imipramine—Immune system disorder—Epirubicin—stomach cancer	0.00014	0.000856	CcSEcCtD
Imipramine—Mediastinal disorder—Epirubicin—stomach cancer	0.00014	0.000855	CcSEcCtD
Imipramine—Constipation—Docetaxel—stomach cancer	0.00014	0.000854	CcSEcCtD
Imipramine—Dyspepsia—Capecitabine—stomach cancer	0.000139	0.000851	CcSEcCtD
Imipramine—Arrhythmia—Epirubicin—stomach cancer	0.000139	0.000847	CcSEcCtD
Imipramine—Decreased appetite—Capecitabine—stomach cancer	0.000137	0.000841	CcSEcCtD
Imipramine—Alopecia—Epirubicin—stomach cancer	0.000137	0.000838	CcSEcCtD
Imipramine—Nortriptyline—HTR1A—stomach cancer	0.000137	0.0255	CrCbGaD
Imipramine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000137	0.000835	CcSEcCtD
Imipramine—Fatigue—Capecitabine—stomach cancer	0.000136	0.000834	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—stomach cancer	0.000136	0.000831	CcSEcCtD
Imipramine—Mental disorder—Epirubicin—stomach cancer	0.000136	0.000831	CcSEcCtD
Imipramine—Constipation—Capecitabine—stomach cancer	0.000135	0.000827	CcSEcCtD
Imipramine—Malnutrition—Epirubicin—stomach cancer	0.000135	0.000825	CcSEcCtD
Imipramine—Feeling abnormal—Docetaxel—stomach cancer	0.000135	0.000823	CcSEcCtD
Imipramine—Nausea—Fluorouracil—stomach cancer	0.000134	0.000822	CcSEcCtD
Imipramine—Eye disorder—Doxorubicin—stomach cancer	0.000134	0.00082	CcSEcCtD
Imipramine—Ill-defined disorder—Methotrexate—stomach cancer	0.000134	0.000818	CcSEcCtD
Imipramine—Tinnitus—Doxorubicin—stomach cancer	0.000134	0.000818	CcSEcCtD
Imipramine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000134	0.000817	CcSEcCtD
Imipramine—Cardiac disorder—Doxorubicin—stomach cancer	0.000133	0.000814	CcSEcCtD
Imipramine—Flushing—Doxorubicin—stomach cancer	0.000133	0.000814	CcSEcCtD
Imipramine—Tension—Epirubicin—stomach cancer	0.000132	0.00081	CcSEcCtD
Imipramine—Dysgeusia—Epirubicin—stomach cancer	0.000132	0.000808	CcSEcCtD
Imipramine—Nervousness—Epirubicin—stomach cancer	0.000131	0.000802	CcSEcCtD
Imipramine—Feeling abnormal—Capecitabine—stomach cancer	0.00013	0.000797	CcSEcCtD
Imipramine—Angiopathy—Doxorubicin—stomach cancer	0.00013	0.000796	CcSEcCtD
Imipramine—Malaise—Methotrexate—stomach cancer	0.00013	0.000795	CcSEcCtD
Imipramine—Immune system disorder—Doxorubicin—stomach cancer	0.00013	0.000792	CcSEcCtD
Imipramine—Desipramine—CYP2A6—stomach cancer	0.000129	0.0242	CrCbGaD
Imipramine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000129	0.000791	CcSEcCtD
Imipramine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000129	0.000791	CcSEcCtD
Imipramine—Body temperature increased—Docetaxel—stomach cancer	0.000129	0.00079	CcSEcCtD
Imipramine—Abdominal pain—Docetaxel—stomach cancer	0.000129	0.00079	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—stomach cancer	0.000129	0.00079	CcSEcCtD
Imipramine—Trimipramine—HTR1A—stomach cancer	0.000129	0.024	CrCbGaD
Imipramine—Arrhythmia—Doxorubicin—stomach cancer	0.000128	0.000784	CcSEcCtD
Imipramine—Vision blurred—Epirubicin—stomach cancer	0.000127	0.000778	CcSEcCtD
Imipramine—Alopecia—Doxorubicin—stomach cancer	0.000127	0.000775	CcSEcCtD
Imipramine—Mental disorder—Doxorubicin—stomach cancer	0.000126	0.000769	CcSEcCtD
Imipramine—Desipramine—ADRB1—stomach cancer	0.000126	0.0235	CrCbGaD
Imipramine—Urticaria—Capecitabine—stomach cancer	0.000126	0.000768	CcSEcCtD
Imipramine—Ill-defined disorder—Epirubicin—stomach cancer	0.000125	0.000766	CcSEcCtD
Imipramine—Body temperature increased—Capecitabine—stomach cancer	0.000125	0.000764	CcSEcCtD
Imipramine—Abdominal pain—Capecitabine—stomach cancer	0.000125	0.000764	CcSEcCtD
Imipramine—Convulsion—Methotrexate—stomach cancer	0.000125	0.000764	CcSEcCtD
Imipramine—Malnutrition—Doxorubicin—stomach cancer	0.000125	0.000764	CcSEcCtD
Imipramine—Agitation—Epirubicin—stomach cancer	0.000124	0.000759	CcSEcCtD
Imipramine—Tension—Doxorubicin—stomach cancer	0.000123	0.000749	CcSEcCtD
Imipramine—Doxepin—HTR1A—stomach cancer	0.000123	0.0229	CrCbGaD
Imipramine—Dysgeusia—Doxorubicin—stomach cancer	0.000122	0.000748	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000122	0.000746	CcSEcCtD
Imipramine—Malaise—Epirubicin—stomach cancer	0.000122	0.000744	CcSEcCtD
Imipramine—Discomfort—Methotrexate—stomach cancer	0.000121	0.000742	CcSEcCtD
Imipramine—Nervousness—Doxorubicin—stomach cancer	0.000121	0.000742	CcSEcCtD
Imipramine—Syncope—Epirubicin—stomach cancer	0.000121	0.00074	CcSEcCtD
Imipramine—Leukopenia—Epirubicin—stomach cancer	0.000121	0.000739	CcSEcCtD
Imipramine—Palpitations—Epirubicin—stomach cancer	0.000119	0.000729	CcSEcCtD
Imipramine—Confusional state—Methotrexate—stomach cancer	0.000119	0.000726	CcSEcCtD
Imipramine—Loss of consciousness—Epirubicin—stomach cancer	0.000119	0.000725	CcSEcCtD
Imipramine—Anaphylactic shock—Methotrexate—stomach cancer	0.000118	0.00072	CcSEcCtD
Imipramine—Vision blurred—Doxorubicin—stomach cancer	0.000118	0.00072	CcSEcCtD
Imipramine—Asthenia—Docetaxel—stomach cancer	0.000117	0.000717	CcSEcCtD
Imipramine—Convulsion—Epirubicin—stomach cancer	0.000117	0.000715	CcSEcCtD
Imipramine—Infection—Methotrexate—stomach cancer	0.000117	0.000715	CcSEcCtD
Imipramine—Hypertension—Epirubicin—stomach cancer	0.000117	0.000713	CcSEcCtD
Imipramine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000116	0.000709	CcSEcCtD
Imipramine—Pruritus—Docetaxel—stomach cancer	0.000116	0.000707	CcSEcCtD
Imipramine—Nervous system disorder—Methotrexate—stomach cancer	0.000115	0.000706	CcSEcCtD
Imipramine—Thrombocytopenia—Methotrexate—stomach cancer	0.000115	0.000705	CcSEcCtD
Imipramine—Agitation—Doxorubicin—stomach cancer	0.000115	0.000702	CcSEcCtD
Imipramine—Anxiety—Epirubicin—stomach cancer	0.000115	0.0007	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—stomach cancer	0.000114	0.000699	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000114	0.000698	CcSEcCtD
Imipramine—Hyperhidrosis—Methotrexate—stomach cancer	0.000114	0.000696	CcSEcCtD
Imipramine—Discomfort—Epirubicin—stomach cancer	0.000114	0.000694	CcSEcCtD
Imipramine—Asthenia—Capecitabine—stomach cancer	0.000113	0.000694	CcSEcCtD
Imipramine—Malaise—Doxorubicin—stomach cancer	0.000113	0.000689	CcSEcCtD
Imipramine—Desipramine—HTR1A—stomach cancer	0.000112	0.021	CrCbGaD
Imipramine—Dry mouth—Epirubicin—stomach cancer	0.000112	0.000687	CcSEcCtD
Imipramine—Anorexia—Methotrexate—stomach cancer	0.000112	0.000686	CcSEcCtD
Imipramine—Syncope—Doxorubicin—stomach cancer	0.000112	0.000685	CcSEcCtD
Imipramine—Pruritus—Capecitabine—stomach cancer	0.000112	0.000684	CcSEcCtD
Imipramine—Leukopenia—Doxorubicin—stomach cancer	0.000112	0.000684	CcSEcCtD
Imipramine—Diarrhoea—Docetaxel—stomach cancer	0.000112	0.000683	CcSEcCtD
Imipramine—Confusional state—Epirubicin—stomach cancer	0.000111	0.000679	CcSEcCtD
Imipramine—ABCB1—lymph node—stomach cancer	0.00011	0.00124	CbGeAlD
Imipramine—Palpitations—Doxorubicin—stomach cancer	0.00011	0.000675	CcSEcCtD
Imipramine—Oedema—Epirubicin—stomach cancer	0.00011	0.000674	CcSEcCtD
Imipramine—Anaphylactic shock—Epirubicin—stomach cancer	0.00011	0.000674	CcSEcCtD
Imipramine—Loss of consciousness—Doxorubicin—stomach cancer	0.00011	0.000671	CcSEcCtD
Imipramine—Infection—Epirubicin—stomach cancer	0.000109	0.000669	CcSEcCtD
Imipramine—Oxcarbazepine—ALB—stomach cancer	0.000109	0.0204	CrCbGaD
Imipramine—Shock—Epirubicin—stomach cancer	0.000108	0.000663	CcSEcCtD
Imipramine—Convulsion—Doxorubicin—stomach cancer	0.000108	0.000662	CcSEcCtD
Imipramine—Diarrhoea—Capecitabine—stomach cancer	0.000108	0.000662	CcSEcCtD
Imipramine—Nervous system disorder—Epirubicin—stomach cancer	0.000108	0.000661	CcSEcCtD
Imipramine—Dizziness—Docetaxel—stomach cancer	0.000108	0.00066	CcSEcCtD
Imipramine—Thrombocytopenia—Epirubicin—stomach cancer	0.000108	0.00066	CcSEcCtD
Imipramine—Hypertension—Doxorubicin—stomach cancer	0.000108	0.000659	CcSEcCtD
Imipramine—Tachycardia—Epirubicin—stomach cancer	0.000108	0.000657	CcSEcCtD
Imipramine—Skin disorder—Epirubicin—stomach cancer	0.000107	0.000654	CcSEcCtD
Imipramine—Hyperhidrosis—Epirubicin—stomach cancer	0.000106	0.000651	CcSEcCtD
Imipramine—Insomnia—Methotrexate—stomach cancer	0.000106	0.000651	CcSEcCtD
Imipramine—Anxiety—Doxorubicin—stomach cancer	0.000106	0.000648	CcSEcCtD
Imipramine—Desipramine—ADRB2—stomach cancer	0.000106	0.0198	CrCbGaD
Imipramine—Paraesthesia—Methotrexate—stomach cancer	0.000106	0.000646	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000106	0.000646	CcSEcCtD
Imipramine—Discomfort—Doxorubicin—stomach cancer	0.000105	0.000642	CcSEcCtD
Imipramine—Anorexia—Epirubicin—stomach cancer	0.000105	0.000642	CcSEcCtD
Imipramine—Somnolence—Methotrexate—stomach cancer	0.000105	0.00064	CcSEcCtD
Imipramine—Dizziness—Capecitabine—stomach cancer	0.000105	0.000639	CcSEcCtD
Imipramine—Dry mouth—Doxorubicin—stomach cancer	0.000104	0.000636	CcSEcCtD
Imipramine—Vomiting—Docetaxel—stomach cancer	0.000104	0.000635	CcSEcCtD
Imipramine—Dyspepsia—Methotrexate—stomach cancer	0.000104	0.000634	CcSEcCtD
Imipramine—Rash—Docetaxel—stomach cancer	0.000103	0.00063	CcSEcCtD
Imipramine—Dermatitis—Docetaxel—stomach cancer	0.000103	0.000629	CcSEcCtD
Imipramine—Confusional state—Doxorubicin—stomach cancer	0.000103	0.000628	CcSEcCtD
Imipramine—Decreased appetite—Methotrexate—stomach cancer	0.000102	0.000626	CcSEcCtD
Imipramine—Headache—Docetaxel—stomach cancer	0.000102	0.000626	CcSEcCtD
Imipramine—Oedema—Doxorubicin—stomach cancer	0.000102	0.000623	CcSEcCtD
Imipramine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000102	0.000623	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000102	0.000621	CcSEcCtD
Imipramine—Fatigue—Methotrexate—stomach cancer	0.000101	0.000621	CcSEcCtD
Imipramine—Infection—Doxorubicin—stomach cancer	0.000101	0.000619	CcSEcCtD
Imipramine—Vomiting—Capecitabine—stomach cancer	0.000101	0.000615	CcSEcCtD
Imipramine—Shock—Doxorubicin—stomach cancer	0.0001	0.000613	CcSEcCtD
Imipramine—Nervous system disorder—Doxorubicin—stomach cancer	0.0001	0.000611	CcSEcCtD
Imipramine—Thrombocytopenia—Doxorubicin—stomach cancer	9.98e-05	0.00061	CcSEcCtD
Imipramine—Rash—Capecitabine—stomach cancer	9.97e-05	0.00061	CcSEcCtD
Imipramine—Insomnia—Epirubicin—stomach cancer	9.96e-05	0.000609	CcSEcCtD
Imipramine—Dermatitis—Capecitabine—stomach cancer	9.96e-05	0.000609	CcSEcCtD
Imipramine—Tachycardia—Doxorubicin—stomach cancer	9.95e-05	0.000608	CcSEcCtD
Imipramine—Headache—Capecitabine—stomach cancer	9.91e-05	0.000606	CcSEcCtD
Imipramine—Skin disorder—Doxorubicin—stomach cancer	9.9e-05	0.000605	CcSEcCtD
Imipramine—Paraesthesia—Epirubicin—stomach cancer	9.89e-05	0.000605	CcSEcCtD
Imipramine—Hyperhidrosis—Doxorubicin—stomach cancer	9.85e-05	0.000603	CcSEcCtD
Imipramine—Somnolence—Epirubicin—stomach cancer	9.79e-05	0.000599	CcSEcCtD
Imipramine—Anorexia—Doxorubicin—stomach cancer	9.72e-05	0.000594	CcSEcCtD
Imipramine—Nausea—Docetaxel—stomach cancer	9.7e-05	0.000593	CcSEcCtD
Imipramine—Feeling abnormal—Methotrexate—stomach cancer	9.7e-05	0.000593	CcSEcCtD
Imipramine—Dyspepsia—Epirubicin—stomach cancer	9.7e-05	0.000593	CcSEcCtD
Imipramine—Gastrointestinal pain—Methotrexate—stomach cancer	9.63e-05	0.000589	CcSEcCtD
Imipramine—Chlorpromazine—HTR1A—stomach cancer	9.59e-05	0.0179	CrCbGaD
Imipramine—Decreased appetite—Epirubicin—stomach cancer	9.58e-05	0.000586	CcSEcCtD
Imipramine—Gastrointestinal disorder—Epirubicin—stomach cancer	9.51e-05	0.000582	CcSEcCtD
Imipramine—Fatigue—Epirubicin—stomach cancer	9.5e-05	0.000581	CcSEcCtD
Imipramine—Amitriptyline—HTR1A—stomach cancer	9.48e-05	0.0177	CrCbGaD
Imipramine—Constipation—Epirubicin—stomach cancer	9.42e-05	0.000576	CcSEcCtD
Imipramine—Nausea—Capecitabine—stomach cancer	9.39e-05	0.000574	CcSEcCtD
Imipramine—Urticaria—Methotrexate—stomach cancer	9.35e-05	0.000572	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—stomach cancer	9.31e-05	0.000569	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—stomach cancer	9.31e-05	0.000569	CcSEcCtD
Imipramine—Insomnia—Doxorubicin—stomach cancer	9.22e-05	0.000564	CcSEcCtD
Imipramine—Paraesthesia—Doxorubicin—stomach cancer	9.15e-05	0.00056	CcSEcCtD
Imipramine—Feeling abnormal—Epirubicin—stomach cancer	9.08e-05	0.000555	CcSEcCtD
Imipramine—Somnolence—Doxorubicin—stomach cancer	9.06e-05	0.000554	CcSEcCtD
Imipramine—Gastrointestinal pain—Epirubicin—stomach cancer	9.01e-05	0.000551	CcSEcCtD
Imipramine—Dyspepsia—Doxorubicin—stomach cancer	8.97e-05	0.000549	CcSEcCtD
Imipramine—Decreased appetite—Doxorubicin—stomach cancer	8.86e-05	0.000542	CcSEcCtD
Imipramine—Gastrointestinal disorder—Doxorubicin—stomach cancer	8.8e-05	0.000538	CcSEcCtD
Imipramine—Fatigue—Doxorubicin—stomach cancer	8.79e-05	0.000537	CcSEcCtD
Imipramine—Urticaria—Epirubicin—stomach cancer	8.75e-05	0.000535	CcSEcCtD
Imipramine—Constipation—Doxorubicin—stomach cancer	8.72e-05	0.000533	CcSEcCtD
Imipramine—Abdominal pain—Epirubicin—stomach cancer	8.71e-05	0.000533	CcSEcCtD
Imipramine—Body temperature increased—Epirubicin—stomach cancer	8.71e-05	0.000533	CcSEcCtD
Imipramine—Asthenia—Methotrexate—stomach cancer	8.45e-05	0.000516	CcSEcCtD
Imipramine—Feeling abnormal—Doxorubicin—stomach cancer	8.4e-05	0.000514	CcSEcCtD
Imipramine—Gastrointestinal pain—Doxorubicin—stomach cancer	8.34e-05	0.00051	CcSEcCtD
Imipramine—Pruritus—Methotrexate—stomach cancer	8.33e-05	0.000509	CcSEcCtD
Imipramine—Acepromazine—ALB—stomach cancer	8.25e-05	0.0154	CrCbGaD
Imipramine—Urticaria—Doxorubicin—stomach cancer	8.1e-05	0.000495	CcSEcCtD
Imipramine—Thioproperazine—ALB—stomach cancer	8.07e-05	0.0151	CrCbGaD
Imipramine—Abdominal pain—Doxorubicin—stomach cancer	8.06e-05	0.000493	CcSEcCtD
Imipramine—Body temperature increased—Doxorubicin—stomach cancer	8.06e-05	0.000493	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—stomach cancer	8.05e-05	0.000493	CcSEcCtD
Imipramine—Pipotiazine—ALB—stomach cancer	7.94e-05	0.0148	CrCbGaD
Imipramine—Asthenia—Epirubicin—stomach cancer	7.9e-05	0.000483	CcSEcCtD
Imipramine—Pruritus—Epirubicin—stomach cancer	7.79e-05	0.000477	CcSEcCtD
Imipramine—Dizziness—Methotrexate—stomach cancer	7.78e-05	0.000476	CcSEcCtD
Imipramine—Diarrhoea—Epirubicin—stomach cancer	7.54e-05	0.000461	CcSEcCtD
Imipramine—Vomiting—Methotrexate—stomach cancer	7.48e-05	0.000458	CcSEcCtD
Imipramine—Rash—Methotrexate—stomach cancer	7.42e-05	0.000454	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—stomach cancer	7.42e-05	0.000453	CcSEcCtD
Imipramine—Headache—Methotrexate—stomach cancer	7.37e-05	0.000451	CcSEcCtD
Imipramine—Asthenia—Doxorubicin—stomach cancer	7.31e-05	0.000447	CcSEcCtD
Imipramine—Dizziness—Epirubicin—stomach cancer	7.28e-05	0.000445	CcSEcCtD
Imipramine—Pruritus—Doxorubicin—stomach cancer	7.21e-05	0.000441	CcSEcCtD
Imipramine—Vomiting—Epirubicin—stomach cancer	7e-05	0.000428	CcSEcCtD
Imipramine—Nausea—Methotrexate—stomach cancer	6.99e-05	0.000428	CcSEcCtD
Imipramine—Diarrhoea—Doxorubicin—stomach cancer	6.97e-05	0.000426	CcSEcCtD
Imipramine—Rash—Epirubicin—stomach cancer	6.95e-05	0.000425	CcSEcCtD
Imipramine—Dermatitis—Epirubicin—stomach cancer	6.94e-05	0.000424	CcSEcCtD
Imipramine—Headache—Epirubicin—stomach cancer	6.9e-05	0.000422	CcSEcCtD
Imipramine—Dizziness—Doxorubicin—stomach cancer	6.74e-05	0.000412	CcSEcCtD
Imipramine—Nausea—Epirubicin—stomach cancer	6.54e-05	0.0004	CcSEcCtD
Imipramine—Vomiting—Doxorubicin—stomach cancer	6.48e-05	0.000396	CcSEcCtD
Imipramine—Rash—Doxorubicin—stomach cancer	6.43e-05	0.000393	CcSEcCtD
Imipramine—Dermatitis—Doxorubicin—stomach cancer	6.42e-05	0.000393	CcSEcCtD
Imipramine—Headache—Doxorubicin—stomach cancer	6.39e-05	0.00039	CcSEcCtD
Imipramine—Clomipramine—ALB—stomach cancer	6.27e-05	0.0117	CrCbGaD
Imipramine—Nortriptyline—ALB—stomach cancer	6.13e-05	0.0115	CrCbGaD
Imipramine—Nausea—Doxorubicin—stomach cancer	6.05e-05	0.00037	CcSEcCtD
Imipramine—Chlorpromazine—ALB—stomach cancer	4.3e-05	0.00804	CrCbGaD
Imipramine—Amitriptyline—ALB—stomach cancer	4.25e-05	0.00795	CrCbGaD
Imipramine—ADRA1B—Signaling Pathways—JUN—stomach cancer	2.86e-06	2.16e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	2.84e-06	2.15e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—KRAS—stomach cancer	2.84e-06	2.14e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK8—stomach cancer	2.84e-06	2.14e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCL8—stomach cancer	2.83e-06	2.14e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK8—stomach cancer	2.82e-06	2.13e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARG—stomach cancer	2.82e-06	2.13e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—HRAS—stomach cancer	2.81e-06	2.12e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCL8—stomach cancer	2.79e-06	2.1e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCL8—stomach cancer	2.78e-06	2.1e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MMP9—stomach cancer	2.78e-06	2.1e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCL8—stomach cancer	2.77e-06	2.09e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—HRAS—stomach cancer	2.77e-06	2.09e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	2.77e-06	2.09e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MYC—stomach cancer	2.77e-06	2.09e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN1B—stomach cancer	2.77e-06	2.09e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—PIK3CA—stomach cancer	2.76e-06	2.09e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCL8—stomach cancer	2.76e-06	2.09e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—HRAS—stomach cancer	2.76e-06	2.09e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—PIK3CA—stomach cancer	2.76e-06	2.08e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—HRAS—stomach cancer	2.75e-06	2.08e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARG—stomach cancer	2.75e-06	2.07e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—HRAS—stomach cancer	2.75e-06	2.07e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCL8—stomach cancer	2.74e-06	2.07e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	2.73e-06	2.06e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	2.72e-06	2.05e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—HRAS—stomach cancer	2.72e-06	2.05e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—KRAS—stomach cancer	2.72e-06	2.05e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	2.72e-06	2.05e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	2.71e-06	2.05e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	2.71e-06	2.04e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	2.71e-06	2.04e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MTHFR—stomach cancer	2.71e-06	2.04e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EGFR—stomach cancer	2.71e-06	2.04e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	2.7e-06	2.04e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	2.7e-06	2.04e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—stomach cancer	2.69e-06	2.03e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—stomach cancer	2.67e-06	2.02e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	2.67e-06	2.02e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—stomach cancer	2.67e-06	2.02e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	2.66e-06	2.01e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—stomach cancer	2.65e-06	2e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—stomach cancer	2.64e-06	2e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCND1—stomach cancer	2.64e-06	1.99e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—stomach cancer	2.64e-06	1.99e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—JUN—stomach cancer	2.63e-06	1.99e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—stomach cancer	2.63e-06	1.98e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.62e-06	1.98e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—stomach cancer	2.62e-06	1.98e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	2.61e-06	1.97e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	2.61e-06	1.97e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—stomach cancer	2.6e-06	1.96e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCND1—stomach cancer	2.6e-06	1.96e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	2.59e-06	1.96e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—STAT3—stomach cancer	2.59e-06	1.96e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—JUN—stomach cancer	2.59e-06	1.96e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCND1—stomach cancer	2.59e-06	1.96e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARG—stomach cancer	2.59e-06	1.96e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—JUN—stomach cancer	2.59e-06	1.95e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCND1—stomach cancer	2.58e-06	1.95e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—STAT3—stomach cancer	2.58e-06	1.95e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—JUN—stomach cancer	2.58e-06	1.95e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCND1—stomach cancer	2.57e-06	1.94e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTP1—stomach cancer	2.57e-06	1.94e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—JUN—stomach cancer	2.57e-06	1.94e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MMP9—stomach cancer	2.56e-06	1.93e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HRAS—stomach cancer	2.56e-06	1.93e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—KRAS—stomach cancer	2.56e-06	1.93e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HRAS—stomach cancer	2.55e-06	1.93e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	2.55e-06	1.93e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCND1—stomach cancer	2.55e-06	1.92e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—JUN—stomach cancer	2.54e-06	1.92e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	2.54e-06	1.92e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—JUN—stomach cancer	2.54e-06	1.92e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HMOX1—stomach cancer	2.54e-06	1.91e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—stomach cancer	2.53e-06	1.91e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—stomach cancer	2.52e-06	1.9e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MMP9—stomach cancer	2.52e-06	1.9e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MMP9—stomach cancer	2.52e-06	1.9e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	2.51e-06	1.9e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MMP9—stomach cancer	2.51e-06	1.89e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	2.51e-06	1.89e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MMP9—stomach cancer	2.5e-06	1.89e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	2.5e-06	1.89e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	2.5e-06	1.89e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CAV1—stomach cancer	2.5e-06	1.88e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	2.5e-06	1.88e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK8—stomach cancer	2.49e-06	1.88e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	2.49e-06	1.88e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOA1—stomach cancer	2.49e-06	1.88e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK3—stomach cancer	2.48e-06	1.87e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MMP9—stomach cancer	2.47e-06	1.87e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—stomach cancer	2.47e-06	1.87e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—STAT3—stomach cancer	2.47e-06	1.87e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	2.47e-06	1.86e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	2.47e-06	1.86e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	2.47e-06	1.86e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	2.46e-06	1.86e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	2.45e-06	1.85e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—stomach cancer	2.45e-06	1.85e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK8—stomach cancer	2.45e-06	1.85e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—stomach cancer	2.45e-06	1.85e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PIK3CA—stomach cancer	2.44e-06	1.84e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK8—stomach cancer	2.44e-06	1.84e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PIK3CA—stomach cancer	2.43e-06	1.84e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK8—stomach cancer	2.43e-06	1.84e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—NOS3—stomach cancer	2.42e-06	1.83e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—stomach cancer	2.42e-06	1.82e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HRAS—stomach cancer	2.41e-06	1.82e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—stomach cancer	2.41e-06	1.82e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK8—stomach cancer	2.41e-06	1.82e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	2.4e-06	1.81e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—stomach cancer	2.4e-06	1.81e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TYMS—stomach cancer	2.39e-06	1.8e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.38e-06	1.8e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—NOS3—stomach cancer	2.36e-06	1.78e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTM1—stomach cancer	2.36e-06	1.78e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	2.36e-06	1.78e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK1—stomach cancer	2.36e-06	1.78e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—stomach cancer	2.36e-06	1.78e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	2.35e-06	1.77e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	2.35e-06	1.77e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—stomach cancer	2.35e-06	1.77e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—stomach cancer	2.33e-06	1.76e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HRAS—stomach cancer	2.31e-06	1.74e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—stomach cancer	2.31e-06	1.74e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.3e-06	1.74e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—stomach cancer	2.3e-06	1.73e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—STAT3—stomach cancer	2.28e-06	1.72e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—stomach cancer	2.27e-06	1.71e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PIK3CA—stomach cancer	2.27e-06	1.71e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	2.26e-06	1.71e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.26e-06	1.71e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—stomach cancer	2.25e-06	1.7e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	2.25e-06	1.7e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—stomach cancer	2.25e-06	1.7e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—stomach cancer	2.24e-06	1.69e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—STAT3—stomach cancer	2.24e-06	1.69e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—STAT3—stomach cancer	2.24e-06	1.69e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—STAT3—stomach cancer	2.23e-06	1.68e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—NOS3—stomach cancer	2.23e-06	1.68e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.23e-06	1.68e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—stomach cancer	2.22e-06	1.68e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—STAT3—stomach cancer	2.22e-06	1.68e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ERCC2—stomach cancer	2.22e-06	1.68e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.22e-06	1.67e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—KRAS—stomach cancer	2.22e-06	1.67e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—stomach cancer	2.21e-06	1.67e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—stomach cancer	2.21e-06	1.67e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—STAT3—stomach cancer	2.2e-06	1.66e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.19e-06	1.66e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARG—stomach cancer	2.19e-06	1.66e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.18e-06	1.64e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HRAS—stomach cancer	2.17e-06	1.64e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—stomach cancer	2.16e-06	1.63e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.14e-06	1.62e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.14e-06	1.61e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK3—stomach cancer	2.13e-06	1.61e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK3—stomach cancer	2.12e-06	1.6e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—KRAS—stomach cancer	2.12e-06	1.6e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—stomach cancer	2.12e-06	1.6e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK3—stomach cancer	2.1e-06	1.59e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.1e-06	1.58e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PIK3CA—stomach cancer	2.1e-06	1.58e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—stomach cancer	2.09e-06	1.58e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—stomach cancer	2.08e-06	1.57e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—stomach cancer	2.08e-06	1.57e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—stomach cancer	2.08e-06	1.57e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—stomach cancer	2.07e-06	1.56e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.07e-06	1.56e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—stomach cancer	2.07e-06	1.56e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—stomach cancer	2.06e-06	1.56e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.05e-06	1.54e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—stomach cancer	2.04e-06	1.54e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.04e-06	1.54e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.04e-06	1.54e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—stomach cancer	2.04e-06	1.54e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.04e-06	1.54e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	2.04e-06	1.54e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK1—stomach cancer	2.03e-06	1.53e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—stomach cancer	2.03e-06	1.53e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK1—stomach cancer	2.03e-06	1.53e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—stomach cancer	2.03e-06	1.53e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK1—stomach cancer	2.02e-06	1.53e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—stomach cancer	2.02e-06	1.52e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK1—stomach cancer	2e-06	1.51e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—stomach cancer	2e-06	1.51e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	1.99e-06	1.51e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	1.99e-06	1.51e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—stomach cancer	1.98e-06	1.49e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—stomach cancer	1.97e-06	1.49e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—stomach cancer	1.97e-06	1.49e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—KRAS—stomach cancer	1.96e-06	1.48e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	1.95e-06	1.47e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAV1—stomach cancer	1.93e-06	1.45e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KRAS—stomach cancer	1.92e-06	1.45e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOA1—stomach cancer	1.92e-06	1.45e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KRAS—stomach cancer	1.92e-06	1.45e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KRAS—stomach cancer	1.91e-06	1.45e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KRAS—stomach cancer	1.91e-06	1.44e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HRAS—stomach cancer	1.89e-06	1.43e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KRAS—stomach cancer	1.89e-06	1.43e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—NOS3—stomach cancer	1.89e-06	1.42e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—stomach cancer	1.89e-06	1.42e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	1.88e-06	1.42e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HRAS—stomach cancer	1.88e-06	1.42e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—stomach cancer	1.81e-06	1.37e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PIK3CA—stomach cancer	1.8e-06	1.36e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HRAS—stomach cancer	1.8e-06	1.36e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—stomach cancer	1.8e-06	1.36e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	1.8e-06	1.36e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	1.77e-06	1.33e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3CA—stomach cancer	1.77e-06	1.33e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	1.76e-06	1.33e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.76e-06	1.33e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.75e-06	1.32e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—stomach cancer	1.74e-06	1.31e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.74e-06	1.31e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	1.73e-06	1.31e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—stomach cancer	1.73e-06	1.3e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—stomach cancer	1.73e-06	1.3e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—stomach cancer	1.71e-06	1.29e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—stomach cancer	1.71e-06	1.29e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—stomach cancer	1.7e-06	1.28e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—stomach cancer	1.7e-06	1.28e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARG—stomach cancer	1.69e-06	1.28e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—stomach cancer	1.68e-06	1.27e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—stomach cancer	1.67e-06	1.26e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HRAS—stomach cancer	1.66e-06	1.26e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HRAS—stomach cancer	1.64e-06	1.23e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HRAS—stomach cancer	1.63e-06	1.23e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.63e-06	1.23e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HRAS—stomach cancer	1.62e-06	1.22e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.61e-06	1.21e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	1.6e-06	1.21e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—stomach cancer	1.59e-06	1.2e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—stomach cancer	1.57e-06	1.18e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—stomach cancer	1.56e-06	1.18e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—stomach cancer	1.56e-06	1.18e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—stomach cancer	1.55e-06	1.17e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—stomach cancer	1.54e-06	1.16e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.53e-06	1.16e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—stomach cancer	1.52e-06	1.15e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NOS3—stomach cancer	1.46e-06	1.1e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.36e-06	1.03e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—stomach cancer	1.33e-06	1.01e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CA—stomach cancer	1.33e-06	1e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.25e-06	9.46e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.06e-06	8.02e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CA—stomach cancer	8.19e-07	6.19e-06	CbGpPWpGaD
